0001209191-12-018573.txt : 20120315 0001209191-12-018573.hdr.sgml : 20120315 20120315174704 ACCESSION NUMBER: 0001209191-12-018573 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120313 FILED AS OF DATE: 20120315 DATE AS OF CHANGE: 20120315 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sullivan Timothy M CENTRAL INDEX KEY: 0001375211 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31918 FILM NUMBER: 12695224 MAIL ADDRESS: STREET 1: 345 VASSAR STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IDERA PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000861838 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 043072298 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 167 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 6176795500 MAIL ADDRESS: STREET 1: 167 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: HYBRIDON INC DATE OF NAME CHANGE: 19951211 4 1 doc4.xml FORM 4 SUBMISSION X0304 4 2012-03-13 0 0000861838 IDERA PHARMACEUTICALS, INC. IDRA 0001375211 Sullivan Timothy M C/O IDERA PHARMACEUTICALS, INC. 167 SIDNEY STREET CAMBRIDGE MA 02139 0 1 0 0 VP Development Programs Stock Option (Right to Buy) 1.157 2012-03-13 4 A 0 9375 0.00 A 2021-11-28 Common Stock 9375 84375 D On December 5, 2011, the reporting person was granted an option to purchase up to an aggregate of 150,000 shares of common stock. Half of the shares subject to such option are subject to satisfaction of performance vesting criteria. On March 13, 2012, certain performance vesting criteria were met with respect to 9,375 of such shares, of which 2,343 shares vested on March 13, 2012 and the remaining 7,032 of which will vest in three equal annual installments beginning on March 13, 2013. /s/ Timothy M. Sullivan 2012-03-15